vs
DOCUSIGN, INC.（DOCU）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是DOCUSIGN, INC.的1.8倍（$1.5B vs $818.4M），Steris净利率更高（12.9% vs 10.2%，领先2.7%），Steris同比增速更快（9.2% vs 8.4%），DOCUSIGN, INC.自由现金流更多（$262.9M vs $199.5M）
DocuSign是总部位于美国加利福尼亚州旧金山的软件企业，为各类机构提供多设备支持的电子协议管理及电子签名相关产品。截至2025年，公司在180个国家拥有约170万客户，其处理的签名符合美国ESIGN法案、欧盟eIDAS法规要求，满足欧盟高级及合格签名标准。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
DOCU vs STE — 直观对比
营收规模更大
STE
是对方的1.8倍
$818.4M
营收增速更快
STE
高出0.7%
8.4%
净利率更高
STE
高出2.7%
10.2%
自由现金流更多
DOCU
多$63.4M
$199.5M
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $818.4M | $1.5B |
| 净利润 | $83.7M | $192.9M |
| 毛利率 | 79.2% | 43.8% |
| 营业利润率 | 10.4% | 18.3% |
| 净利率 | 10.2% | 12.9% |
| 营收同比 | 8.4% | 9.2% |
| 净利润同比 | 34.1% | 11.2% |
| 每股收益（稀释后） | $0.40 | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCUSTE
| Q4 25 | $818.4M | $1.5B | ||
| Q3 25 | $800.6M | $1.5B | ||
| Q2 25 | $763.7M | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.1B |
净利润DOCUSTE
| Q4 25 | $83.7M | $192.9M | ||
| Q3 25 | $63.0M | $191.9M | ||
| Q2 25 | $72.1M | $177.4M | ||
| Q1 25 | — | $145.7M | ||
| Q4 24 | — | $173.5M | ||
| Q3 24 | — | $150.0M | ||
| Q2 24 | — | $145.4M | ||
| Q1 24 | — | $-1.4M |
毛利率DOCUSTE
| Q4 25 | 79.2% | 43.8% | ||
| Q3 25 | 79.3% | 44.2% | ||
| Q2 25 | 79.4% | 45.1% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 44.5% | ||
| Q3 24 | — | 43.6% | ||
| Q2 24 | — | 44.7% | ||
| Q1 24 | — | 40.2% |
营业利润率DOCUSTE
| Q4 25 | 10.4% | 18.3% | ||
| Q3 25 | 8.1% | 18.2% | ||
| Q2 25 | 7.9% | 17.7% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 17.9% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | — | 14.5% | ||
| Q1 24 | — | 22.0% |
净利率DOCUSTE
| Q4 25 | 10.2% | 12.9% | ||
| Q3 25 | 7.9% | 13.1% | ||
| Q2 25 | 9.4% | 12.8% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 11.4% | ||
| Q1 24 | — | -0.1% |
每股收益（稀释后）DOCUSTE
| Q4 25 | $0.40 | $1.96 | ||
| Q3 25 | $0.30 | $1.94 | ||
| Q2 25 | $0.34 | $1.79 | ||
| Q1 25 | — | $1.48 | ||
| Q4 24 | — | $1.75 | ||
| Q3 24 | — | $1.51 | ||
| Q2 24 | — | $1.46 | ||
| Q1 24 | — | $-0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $583.3M | $423.7M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $2.0B | $7.2B |
| 总资产 | $4.0B | $10.6B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资DOCUSTE
| Q4 25 | $583.3M | $423.7M | ||
| Q3 25 | $600.0M | $319.2M | ||
| Q2 25 | $657.4M | $279.7M | ||
| Q1 25 | — | $171.7M | ||
| Q4 24 | — | $155.2M | ||
| Q3 24 | — | $172.2M | ||
| Q2 24 | — | $198.3M | ||
| Q1 24 | — | $207.0M |
总债务DOCUSTE
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $3.1B |
股东权益DOCUSTE
| Q4 25 | $2.0B | $7.2B | ||
| Q3 25 | $2.0B | $7.0B | ||
| Q2 25 | $2.0B | $7.0B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.4B | ||
| Q3 24 | — | $6.6B | ||
| Q2 24 | — | $6.4B | ||
| Q1 24 | — | $6.3B |
总资产DOCUSTE
| Q4 25 | $4.0B | $10.6B | ||
| Q3 25 | $3.9B | $10.4B | ||
| Q2 25 | $3.9B | $10.4B | ||
| Q1 25 | — | $10.1B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $10.2B | ||
| Q2 24 | — | $10.1B | ||
| Q1 24 | — | $11.1B |
负债/权益比DOCUSTE
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.33× | ||
| Q2 24 | — | 0.35× | ||
| Q1 24 | — | 0.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $290.3M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | $262.9M | $199.5M |
| 自由现金流率自由现金流/营收 | 32.1% | 13.3% |
| 资本支出强度资本支出/营收 | 3.3% | 6.6% |
| 现金转化率经营现金流/净利润 | 3.47× | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流DOCUSTE
| Q4 25 | $290.3M | $298.2M | ||
| Q3 25 | $246.1M | $287.8M | ||
| Q2 25 | $251.4M | $420.0M | ||
| Q1 25 | — | $260.8M | ||
| Q4 24 | — | $332.8M | ||
| Q3 24 | — | $250.7M | ||
| Q2 24 | — | $303.7M | ||
| Q1 24 | — | $254.8M |
自由现金流DOCUSTE
| Q4 25 | $262.9M | $199.5M | ||
| Q3 25 | $217.6M | $201.3M | ||
| Q2 25 | $227.8M | $326.4M | ||
| Q1 25 | — | $189.9M | ||
| Q4 24 | — | $243.6M | ||
| Q3 24 | — | $148.8M | ||
| Q2 24 | — | $195.7M | ||
| Q1 24 | — | $163.3M |
自由现金流率DOCUSTE
| Q4 25 | 32.1% | 13.3% | ||
| Q3 25 | 27.2% | 13.8% | ||
| Q2 25 | 29.8% | 23.5% | ||
| Q1 25 | — | 12.8% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 15.3% | ||
| Q1 24 | — | 14.6% |
资本支出强度DOCUSTE
| Q4 25 | 3.3% | 6.6% | ||
| Q3 25 | 3.6% | 5.9% | ||
| Q2 25 | 3.1% | 6.7% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 8.2% |
现金转化率DOCUSTE
| Q4 25 | 3.47× | 1.55× | ||
| Q3 25 | 3.91× | 1.50× | ||
| Q2 25 | 3.49× | 2.37× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.67× | ||
| Q2 24 | — | 2.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCU
| Subscription And Circulation | $801.0M | 98% |
| Professional Services And Other | $17.4M | 2% |
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
